hemispherHemispherx Biopharma has hired Squire Patton Boggs as its global government relations firm to pursue distribution opportunities for its two Ebola drugs.

The DC lobbying powerhouse will focus on outreach to officials in Africa, Europe and the US.

Tom Equels, executive vice chairman of the Philadelphia-based firm, said SPB is promoting Hemispherx's experimental drug Ampligen and FDA- approved drug Alferon N as potential therapeutics for Ebola.

"This strategic alliance will dramatically enhance our future efforts to try to save lives and alleviate human suffering resulting from these lethal worldwide threats," he said in a statement.

SPB has offices in 21 countries.